A Woman May Have Been Cured of H.I.V. Without Medical Treatment
In dozens of other patients who suppress the virus without drugs, it seems to have been cornered in parts of the genome where it cannot reproduce, scientists reported. (Source: NYT Health)
Source: NYT Health - August 27, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Acquired Immune Deficiency Syndrome Genetics and Heredity Immune System Bone Marrow Transplants your-feed-science Nature (Journal) Harvard University Source Type: news

UArizona Health Sciences researcher seeks safer, more effective leukemia treatment
(University of Arizona Health Sciences) A potentially safer, more effective chemotherapy treatment for patients with blood-related cancers, such as leukemia, who need a particular bone marrow transplant procedure is under study at the University of Arizona Health Sciences. The procedure is known as a haploidentical (half-matched) bone marrow transplantation, or " haplo-BMT, " providng an alternate source of stem cells for patients needing a bone marrow transplant but unable to find a perfect or near-perfect donor match for human leukocyte antigens. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 3, 2020 Category: Cancer & Oncology Source Type: news

Two Cohrane Croatia members receive awards from the city of Split for 2019
Irena Zakarija Grkovi ć, co-director of Cochrane Croatia, and Matko Marušić, head of quality assurance at Cochrane Croatia, both received awards from the city of Split.  The Split City Council, on May 4, 2020, decided that the traditional awards of the city of Split should be given to two members of theCochrane  Croatia. The personal award was given to Irena Zakarija Grkovi ć, co-director of Cochrane Croatia, for selfless commitment and work on the popularization of breastfeeding. A second award was given to Matko Marušić, head of quality assurance at Cochrane Croatia, for the boo...
Source: Cochrane News and Events - July 8, 2020 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Two Cochrane Croatia members receive awards from the city of Split for 2019
Irena Zakarija Grkovi ć, co-director of Cochrane Croatia, and Matko Marušić, head of quality assurance at Cochrane Croatia, both received awards from the city of Split.  The Split City Council, on May 4, 2020, decided that the traditional awards of the city of Split should be given to two members of theCochrane  Croatia. The personal award was given to Irena Zakarija Grkovi ć, co-director of Cochrane Croatia, for selfless commitment and work on the popularization of breastfeeding. A second award was given to Matko Marušić, head of quality assurance at Cochrane Croatia, for the boo...
Source: Cochrane News and Events - July 8, 2020 Category: Information Technology Authors: Muriah Umoquit Source Type: news

More Covid-19 guidelines from NICE
NICE has published more “rapid” guidelines, this time covering provision of radiotherapy services and bone marrow transplant during the Covid-19 pandemic. (Source: NHS Networks)
Source: NHS Networks - April 2, 2020 Category: UK Health Source Type: news

Evolving HTA frameworks to accelerate innovation
Innovation in the cancer treatment space offers great promise, but even when approved by the European Medicines Agency (EMA) and other national regulatory bodies, patients can still face protracted delays in accessing new treatments.    Uncertainties in the evidence base for pioneering therapies can lead to delays from health technology assessment (HTA) agencies and payers in securing reimbursement.    To accelerate progress here, HTA frameworks must evolve, says Clare Hague, Therapy Area Market Access Lead, Hematology at Janssen EMEA, speaking ahead of the upcoming eyeforpharma Barcelona 2020 confere...
Source: EyeForPharma - March 14, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Evolving HTA frameworks to accelerate innovation
Innovation in the cancer treatment space offers great promise, but even when approved by the European Medicines Agency (EMA) and other national regulatory bodies, patients can still face protracted delays in accessing new treatments.    Uncertainties in the evidence base for pioneering therapies can lead to delays from health technology assessment (HTA) agencies and payers in securing reimbursement.    To accelerate progress here, HTA frameworks must evolve, says Clare Hague, Therapy Area Market Access Lead, Hematology at Janssen EMEA, speaking ahead of the upcoming eyeforpharma Barcelona 2020 confere...
Source: EyeForPharma - March 14, 2020 Category: Pharmaceuticals Authors: Andrew Stone Source Type: news

Second person cleared of HIV remains free of virus one year on
Researchers reveal Adam Castillejo still in remission 12 months after ‘cure’ declaredThe patient who became the second person ever to be cleared of HIV remains free of the virus a year after initial reports of a “cure”, researchers have revealed.Adam Castillejo, who wasuntil Monday known only as the “London patient”,wasdeclared free of HIV last year, 18 months after stopping antiretroviral therapy following a stem cell, or bone marrow, transplant to treat a type of blood cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 10, 2020 Category: Science Authors: Nicola Davis Tags: Aids and HIV Medical research Science London UK news Health Society Source Type: news

The 'London patient' who was CURED of HIV reveals his identity
Adam Castillejo, 40, was known only as the 'London patient' until today. He was anonymised by doctors who revealed he had been cured of HIV after having a bone marrow transplant for blood cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 9, 2020 Category: Consumer Health News Source Type: news

Tanzania: Hospital Gets Set for Bone Marrow Feat
[Daily News] MUHIMBILI National Hospital (MNH) is finalising procedures for embarking on bone marrow transplants by the end of March this year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 22, 2020 Category: African Health Source Type: news

What Conditions Do You Need a Bone Marrow Transplant for?
Title: What Conditions Do You Need a Bone Marrow Transplant for?Category: Diseases and ConditionsCreated: 2/20/2020 12:00:00 AMLast Editorial Review: 2/20/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 20, 2020 Category: Cancer & Oncology Source Type: news

Bone Marrow Transplant Risks and Survival Rate
Title: Bone Marrow Transplant Risks and Survival RateCategory: Diseases and ConditionsCreated: 2/20/2020 12:00:00 AMLast Editorial Review: 2/20/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 20, 2020 Category: Cancer & Oncology Source Type: news

Outcomes After Bone Marrow Transplants Continue to Improve Outcomes After Bone Marrow Transplants Continue to Improve
The downward trajectory in mortality rates first documented in the early 2000s continues among bone marrow transplant recipients due to small, additive steps that collectively have improved outcomes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 31, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Bone Marrow Transplants Less Risky Now
Title: Bone Marrow Transplants Less Risky NowCategory: Health NewsCreated: 1/29/2020 12:00:00 AMLast Editorial Review: 1/30/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 30, 2020 Category: Cancer & Oncology Source Type: news

Bone Marrow Transplants Less Risky Now
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 29, 2020 Category: Cancer & Oncology Tags: Family Medicine, Nursing, Oncology, Organ Transplants, News, Source Type: news

Bone Marrow Transplants Less Risky Now
WEDNESDAY, Jan. 29, 2020 -- The risks faced by U.S. bone marrow transplant patients have dropped sharply, a new study shows. While this type of transplant can be lifesaving for patients with blood cancers (such as leukemia) and other diseases,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 29, 2020 Category: General Medicine Source Type: news

Six patients with rare blood disease are doing well after gene therapy clinical trial
UCLA researchers are part of an international team that reported the use of a stem cell gene therapy to treat nine people with the rare, inherited blood disease known as X-linked chronic granulomatous disease, or X-CGD. Six of those patients are now in remission and have stopped other treatments. Before now, people with X-CGD – which causes recurrent infections, prolonged hospitalizations for treatment, and a shortened lifespan – had to rely on bone marrow donations for a chance at remission.“With this gene therapy, you can use a patient’s own stem cells instead of donor cells for a transplant,&rdqu...
Source: UCLA Newsroom: Health Sciences - January 28, 2020 Category: Universities & Medical Training Source Type: news

Big gains in bone marrow transplant survival since mid-2000s
(Fred Hutchinson Cancer Research Center) A bone marrow transplant can be a lifesaving treatment, but it can come with life-threatening risks. The encouraging news for patients: Those risks have been plummeting for years. The overall risk of death after transplant dropped 34% between 2003-2007 and 2013-2017, according to an analysis published in the Jan. 21 issue of the Annals of Internal Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 20, 2020 Category: International Medicine & Public Health Source Type: news

Blood stem cell research
(University of Delaware) A nanoparticle carrier system that could eliminate the need for bone marrow transplants, which are both expensive and difficult for patients to undergo. The University of Delaware's Emily Day, an assistant professor of biomedical engineering, is developing a platform that could treat stem cells directly without the need to remove them from the body. Her work has been recognized with an award from the University City Science Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2020 Category: International Medicine & Public Health Source Type: news

Eligible for two schemes but these patients still can't get money for transplants
Eleven-year-old Sameer from Bihar ’s Muzaffarpur district is suffering from aplastic anaemia, and needs Rs 12 lakh for a bone marrow transplant. You would think that’s not a big hurdle since his mother’s name figures in the list of Ayushman Bharat beneficiaries but unfortunately his condition isn’t covered by the scheme. (Source: The Economic Times)
Source: The Economic Times - December 22, 2019 Category: Consumer Health News Source Type: news

Medical doctors STUNNED as bone marrow transplant for leukemia treatment changes man’s DNA, proving medical interventions can OVERWRITE your genetic code
(Natural News) A Nevada man was shocked to learn that a bone marrow transplant he received actually changed his DNA and replaced it with that of his German donor. Chris Long of Reno is currently in remission from acute myeloid leukemia. Three months after his bone marrow transplant operation, he discovered that the DNA in... (Source: NaturalNews.com)
Source: NaturalNews.com - December 19, 2019 Category: Consumer Health News Source Type: news

Jefferson, Temple sign definitive agreement for sale of Fox Chase Cancer Center
Thomas Jefferson University entered into a binding agreement Wednesday with Temple University under which Jefferson will acquire Fox Chase Cancer Center and Temple's bone marrow transplant program. The deal, which will require regulatory approvals, doesn't end there. Jefferson and Temple, which reached a preliminary deal back in July, said they also plan to collaborate in a variety of areas including cancer research and treatment, caring for the underserved, driving innovation, and increasi ng educational… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 18, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

Heart and lung transplant patients celebrate the gift of life
Esteban Jaramillo, 38, received a double lung transplant at Ronald Reagan UCLA Medical Center this past August after both of his lungs collapsed. He had faced health challenges in the past, having undergone a bone marrow transplant 14 years ago, but he didn ’t expect to develop a lung condition as well. Despite these hardships, Jaramillo remained hopeful.“Since I was a kid my grandma told me to have a lot of faith,” he said. “UCLA is a place where miracles of science really happen. I got my life back here.”Jaramillo ’s success story is one of many that were celebrated recently at the UCL...
Source: UCLA Newsroom: Health Sciences - December 17, 2019 Category: Universities & Medical Training Source Type: news

The Case of a Man With Two Sets of DNA Raises More Questions
A crime lab studied a patient ’s response to a bone marrow transplant. Readers requested more information about the perplexing findings. (Source: NYT Health)
Source: NYT Health - December 12, 2019 Category: Consumer Health News Authors: Heather Murphy Tags: Bone Marrow Forensic Science DNA (Deoxyribonucleic Acid) Sperm Transplants Coop, Graham Source Type: news

Nigeria: Nigerian Reseacher Flays Promotion of Bone Marrow Transplant for HIV/Aids Cure
[Vanguard] A Nigerian researcher, Prof. Maduike Ezeibe, has frowned at the analytical treatment interruption, otherwise known as bone marrow transplant, being promoted as cure for HIV/AIDS. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - December 12, 2019 Category: Infectious Diseases Source Type: news

When a DNA Test Says You ’re a Younger Man, Who Lives 5,000 Miles Away
After a bone marrow transplant, a man with leukemia found that his donor ’s DNA traveled to unexpected parts of his body. A crime lab is now studying the case. (Source: NYT Health)
Source: NYT Health - December 7, 2019 Category: Consumer Health News Authors: Heather Murphy Tags: Forensic Science Genetics and Heredity Bone Marrow DNA (Deoxyribonucleic Acid) Transplants Crime and Criminals Source Type: news

A big step toward curbing graft-vs.-host disease after bone marrow transplant
(Boston Children's Hospital) Children needing a bone marrow transplant often lack a fully matched donor and face a risk of acute, life-threatening graft-versus-host disease (GVHD). Now there's reason to hope: An arthritis drug that also can prevent GvHD is getting closer to FDA approval. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2019 Category: Cancer & Oncology Source Type: news

Researchers identify protein that governs human blood stem cell self-renewal
UCLA scientists have discovered a link between a protein and the ability of human blood stem cells to self-renew. In astudy published today in the journal Nature, the team reports that activating the protein causes blood stem cells to self-renew at least twelvefold in laboratory conditions.Multiplying blood stem cells in conditions outside the human body could greatly improve treatment options for blood cancers like leukemia and for many inherited blood diseases.Dr. Hanna Mikkola, a member of the  Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA and senior author of the study, h...
Source: UCLA Newsroom: Health Sciences - November 27, 2019 Category: Universities & Medical Training Source Type: news

Medical News Today: What to know about bone marrow transplants
Bone marrow transplants help treat certain health issues by replacing damaged blood cells with healthy cells. Here, we look at the types and risks of these transplants, as well as how to prepare and the recovery process. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 14, 2019 Category: Consumer Health News Tags: Bones / Orthopedics Source Type: news

For Taunton Children Battling Rare Disease, Flu Season Is Life Or Death
TAUNTON (CBS) – Flu season is here, and for a Taunton family with two babies battling a rare disease, the months are particularly stressful. From the outside, they appear picture-perfect: Amanda and Billy Bettuchi and their three beautiful kids. But you can’t tell a whole health story just by looking. “It’s Severe Combined Immunodeficiency (SCID), so Shane was born with no immune system at all. They have to go through chemo first for 10 days and then they get the bone marrow transplant after that at three months old,” mom Amanda (Acorn) Bettuchi explained. Sweet Shane, not even a year old, is ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 9, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston Syndicated Local flu season Juli McDonald Taunton News Source Type: news

Three UCLA scientists receive grants totaling more than $18 million
Three researchers at the  Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state’s stem cell agency. The recipients areDr. Sophie Deng, professor of ophthalmology at the UCLA Stein Eye Institute;  Yvonne Chen, a UCLA associate professor of microbiology, immunology and molecular genetics; andDr. Caroline Kuo, a UCLA assistant clinical professor of pediatrics. The awards were announced at a CIRM meeting today.Deng ’s four-year, $10.3 million award ...
Source: UCLA Newsroom: Health Sciences - October 31, 2019 Category: Universities & Medical Training Source Type: news

Viagra may be the secret to better bone marrow transplants, mouse study finds
A new study from the University of California Santa Cruz gave mice a dose of Viagra followed by an injection of another drug. It helped stem cells detach from bone marrow in just two hours. (Source: the Mail online | Health)
Source: the Mail online | Health - October 10, 2019 Category: Consumer Health News Source Type: news

Expanded pediatric BMT unit gives children more freedom to move around during treatment and a chance to play
For some kids with cancer and blood disorders, a blood and marrow transplant (BMT), also called a bone marrow transplant, can be their best hope to beat the condition. Atrium Health’s Levine Children’s Hospital has one of the few dedicated pediatric BMT units in the Southeast, offering both physical and emotional care. The unit treats cancers, as well as non-malignant blood disorders (like sickle cell disease) and immunodeficiencies with survival rates in th e top 10 in the country. And now,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 1, 2019 Category: Biotechnology Authors: Atrium Health Source Type: news

Mother begs people to donate blood as her two-year-old is only being kept alive by transfusions
Steph Davidson's daughter Adeline relies on blood transfusions while she waits for a bone marrow transplant. Adeline, from Scotland, has low levels of platelets and red and white blood cells. (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2019 Category: Consumer Health News Source Type: news

Mayo Clinic Q and A: Bone marrow transplants save lives -- more donors are needed
DEAR MAYO CLINIC: Who can be a bone marrow donor? What's the process for becoming one? ANSWER: In general, anyone between the ages of 18 and 60 who's in good health can be a bone marrow donor. To be considered, all you need to do is join the national registry of potential donors. People who [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 13, 2019 Category: Databases & Libraries Source Type: news

Drug accelerates blood system's recovery after chemotherapy, radiation
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans, the compound could help people recover quicker from chemotherapy, radiation and bone marrow transplants. (Source: World Pharma News)
Source: World Pharma News - August 15, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Drug accelerates blood system ’s recovery after chemotherapy, radiation
A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans, the compound could help people recover quicker from chemotherapy, radiation and bone marrow transplants.The study, published in Nature Communications,also sheds light on the basic biology behind blood stem cell regeneration and the role of a specific molecular process that is blocked by the new drug. Blood stem cells reside in the bone marrow and produce all of the body ’s blood and immune cells.“We’re very excite...
Source: UCLA Newsroom: Health Sciences - August 15, 2019 Category: Universities & Medical Training Source Type: news

Helping transplanted stem cells stick around and do their jobs
(Wyss Institute for Biologically Inspired Engineering at Harvard) Delivering mesenchymal stromal cells (MSCs) along with therapeutic stem cells has the potential to reduce host-vs-graft disease and transplant rejection, but MSCs have been plagued by high clearance from the body and immune attack. A new hydrogel-based encapsulation method developed at the Wyss Institute not only protects MSCs from immune attack and clearance, but dramatically improved   the success of bone marrow transplants in mice, paving the way for more effective cell therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 15, 2019 Category: Cancer & Oncology Source Type: news

Mayo Clinic Minute: Why bone marrow donor diversity is needed
Bone marrow transplants are procedures that infuse healthy blood stem cells into your body to replace damaged or diseased bone marrow. Just like people in need of solid organ transplants, such as hearts or kidneys, people in need of a bone marrow transplant have to find a matching donor. Dr. Ernesto Ayala, a Mayo Clinic [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 10, 2019 Category: Databases & Libraries Source Type: news

The growing need for bone marrow donors
Close to 5,000 people in the U.S. undergo a bone marrow transplant annually. Also known as a stem cell transplant, this procedure replaces damaged or diseased bone marrow with healthy cells. The process involves wiping out the body's bone marrow and immune system with chemotherapy and sometimes radiation. Then healthy donor cells are infused intravenously [...] (Source: Mayo Clinic Florida News)
Source: Mayo Clinic Florida News - July 8, 2019 Category: Hospital Management Source Type: news

What Infectious Diseases are Important to Consider in Transplantation Patients?
Discussion Transplantation is not a common problem for primary care physicians but when a child’s disease has progressed to end-stage organ failure, transplantation can be the only treatment available. While the primary care provider usually is not involved in the daily management of patients before, during and after transplantation, they can be involved in many areas. These can include providing appropriate primary and acute care, ordering and obtaining necessary medical tests, medications and equipment, assisting with medical insurance, providing medical history and records to consultants, translating medical infor...
Source: PediatricEducation.org - June 24, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Employers Are Steering Workers Toward Controversial Stem Cell Therapies
A Midwestern grocery chain, Hy-Vee, is taking an unusual—and highly controversial—approach to reducing health care costs. Before employees in certain cities can undergo knee replacement, they first must visit a stem cell provider. Hy-Vee has contracted with one of the U.S.’ leading stem cell companies—Regenexx, based in Des Moines, Iowa—that claims injections of concentrated bone marrow or platelets can help patients avoid expensive joint surgery. Regenexx has persuaded over 100 employers to include its services in their health insurance plans. In a marketing booklet, Regenexx, whose injection...
Source: TIME: Health - June 19, 2019 Category: Consumer Health News Authors: Liz Szabo / Kaiser Health News Tags: Uncategorized Healthcare medicine Source Type: news

Feds: Vietnamese brothers can come to US to save brother
Federal officials who barred two Vietnamese brothers from coming to the U.S. to provide bone-marrow transplants that could save another sibling's life have reversed that decision (Source: ABC News: Health)
Source: ABC News: Health - June 19, 2019 Category: Consumer Health News Tags: Health Source Type: news

A bone marrow transplant saved boy, 10, from cancer - then nearly killed him
Danny Feltwell Jr, 10, suffered from non-Hodgkin lymphoma. A bone marrow transplant treated his relapse, but then he got graft-versus-host disease. An experimental treatment has him back to pitching. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2019 Category: Consumer Health News Source Type: news

Boy battles rare disorder as family searches for donor to match their mixed-race son's bone marrow 
Asaya Bullock, seven, of Parkchester, New York, was diagnosed with IPEX syndrome when he was born. The only cure is a bone marrow transplant, but this is difficult for Asaya, who is mixed-race. (Source: the Mail online | Health)
Source: the Mail online | Health - May 29, 2019 Category: Consumer Health News Source Type: news

Incyte's Jakafi Gets FDA Approval to Treat Graft vs Host Disease Incyte's Jakafi Gets FDA Approval to Treat Graft vs Host Disease
The U.S. Food and Drug Administration on Friday approved Incyte Corp's treatment for acute Graft versus Host disease (GvHD), an inflammatory response by the immune system after a bone marrow transplant.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 29, 2019 Category: Transplant Surgery Tags: Family Medicine/Primary Care News Source Type: news

A wake for a Venezuelan boy, and a nation's anguish
The deaths of several cancer-stricken Venezuelan children who were awaiting bone marrow transplants have ignited a bitter dispute between the government and opponents over who is to blame (Source: ABC News: Health)
Source: ABC News: Health - May 28, 2019 Category: Consumer Health News Tags: Health Source Type: news

Incyte's Jakafi gets FDA approval to treat Graft vs Host Disease
The U.S. Food and Drug Administration on Friday approved Incyte Corp's treatment for acute Graft versus Host disease (GvHD), an inflammatory response by the immune system after a bone marrow transplant. (Source: Reuters: Health)
Source: Reuters: Health - May 24, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Overlooked molecular machine in cell nucleus may hold key to treating aggressive leukemia
(Cincinnati Children's Hospital Medical Center) Many people fighting a very aggressive form of acute myeloid leukemia (AML) don't survive more than five years. These very sick patients are often unable to receive the only cure -- a bone marrow transplant. Now, an international team of scientists report in Nature Cell Biology on a long-overlooked part of a leukemic cell's internal machinery, where they may have found a key to treating the aggressive blood cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 22, 2019 Category: Cancer & Oncology Source Type: news